ChemicalBook > CAS DataBase List > EZM0414

EZM0414

Product Name
EZM0414
CAS No.
2411748-50-8
Chemical Name
EZM0414
Synonyms
EZM0414
CBNumber
CB110828961
Molecular Formula
C22H29FN4O2
Formula Weight
400.5
MOL File
2411748-50-8.mol
More
Less

EZM0414 Property

storage temp. 
Store at -20°C
form 
Solid
color 
Off-white to light yellow
InChIKey
PGNLXEBQMQHFNK-XGTFWIOGNA-N
SMILES
FC1C=CC(C)=C2NC(C(=O)N[C@@H]3CCC[C@H](N4CCN(C(=O)C)CC4)C3)=CC=12 |&1:12,16,r|
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

EZM0414 Chemical Properties,Usage,Production

Uses

EZM0414 is a potent, selective, orally bioavailable inhibitor of SETD2 (IC50=18 nM in SETD2 biochemical assay; IC50=34 nM in cellular assay). EZM0414 can be used for the research of relapsed or refractory multiple myeloma and diffuse large B-cell lymphoma[1].

in vivo

EZM0414 (15 and 30 mg/kg, p.o., BID, daily, ) inhibits tumor growth in NOD SCID mouse xenograft model implanted with human KMS-11 cells, and is well-tolerated[3].
EZM0414 (50 mg/kg, p.o.) shows almost 100% oral bioavailability in rats and mice, t1/2 of 1.8 h (mice)and 3.8 h (rats)[3].

IC 50

SETD2/KMT3A

References

[1] Jennifer Totman, et al. Pharmacologic Inhibition of the Histone Methyltransferase SETD2 with EZM0414 As a Novel Therapeutic Strategy in Relapsed or Refractory Multiple Myeloma and Diffuse Large B-cell Lymphoma.
[2] Jennifer Totman, et al. Pharmacologic Inhibition of the Histone Methyltransferase SETD2 with EZM0414 As a Novel Therapeutic Strategy in Relapsed or Refractory Multiple Myeloma and Diffuse Large B-Cell Lymphoma. Blood. Volume 138, Supplement 1, 23 November 2021, Page 1142.
[3] Alford JS, et al. Conformational-Design-Driven Discovery of EZM0414: A Selective, Potent SETD2 Inhibitor for Clinical Studies. ACS Med Chem Lett. 2022 Jun 7;13(7):1137-1143. DOI:10.1021/acsmedchemlett.2c00167

EZM0414 Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

EZM0414 Suppliers

WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
Tel
17702719238 18971495150;
Email
sales@sun-shinechem.com
Country
China
ProdList
1077
Advantage
64
ShangHai Caerulum Pharma Discovery Co., Ltd.
Tel
18149758185
Email
sales-cpd@caerulumpharma.com
Country
China
ProdList
3506
Advantage
58
Shanghai Lollane Biological Technology Co.,Ltd.
Tel
021-52996696,15000506266 15000506266
Fax
+86-21-52996696
Country
China
ProdList
4757
Advantage
55
Chengdu DingDang Pharmaceutical Co., Ltd.
Tel
028-86040038 13980902949;
Fax
028-85149890
Email
market@dingdangchem.com
Country
China
ProdList
1853
Advantage
55
Shanghai EFE Biological Technology Co., Ltd.
Tel
021-65675885 18964387627
Fax
021-65675885
Email
info@efebio.com
Country
China
ProdList
9803
Advantage
58
Shanghai Kaimo Pharmaceutical Co., Ltd.
Tel
021-50521023 18019779209
Fax
QQ2522822918
Email
sales@kaimopharm.com
Country
China
ProdList
227
Advantage
58
TargetMol Chemicals Inc.
Tel
+1-781-999-5354; +17819995354
Email
marketing@targetmol.com
Country
United States
ProdList
32435
Advantage
58
Suzhou youruike Chemical Pharmaceutical Technology Co., Ltd
Tel
15317229551
Fax
QQ:3607245178
Email
15151849396@163.com
Country
China
ProdList
989
Advantage
58
Chunchuang (Wuhan) Technology Co., Ltd
Tel
15727060112
Email
yutianchun2007@126.com
Country
China
ProdList
9814
Advantage
58
Nantong Hi-Future Biotechnology Co., Ltd
Tel
18051384581
Email
sales@chemhifuture.com
Country
China
ProdList
2995
Advantage
58

2411748-50-8, EZM0414Related Search:


  • EZM0414
  • 2411748-50-8
  • 241748-50-8
  • APIS